Advertisement

Experientia

, Volume 46, Issue 10, pp 1032–1037 | Cite as

Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells

  • Y. K. Hoh
  • E. H. Lim
  • S. O. Ooi
  • O. L. Kon
Research Articles

Summary

Nonsteroidal antiestrogens reversibly and specifically inhibited the proliferation of two estrogen receptornegative lymphoid cell lines (EL4 and Raji) in a dose-dependent manner. [3H]Thymidine incorporation of concanavalin A-stimulated primary splenocytes was also inhibited by 10−6 M clomiphene (1-[4-(2-diethylaminoethoxy)phenyl]-1,2-diphenyl-2-chloroethylene). The antiproliferative effect could be prevented by the simultaneous presence in the growth medium of 10−5 M linoleic acid or 10−5 M arachidonic acid but not by 10−6 M estradiol. Both lymphoid cell lines had high affinity antiestrogen-binding sites whose affinity could be altered by conditions of growth. Growth of EL4 cells in RPMI 1640 medium supplemented with charcoal-pretreated 5% fetal calf serum (charcoal-stripped medium) resulted in significantly higher affinity (Kd 0.54 nM±0.11 nM; n=6) than growth in medium supplemented with untreated serum (complete medium) (Kd=1.68 nM±0.48 nM; n=6) (p<0.001). This change in affinity was partly due to removal of fatty acids from the growth medium by charcoal pretreatment, since addition of 10−5 M linoleic acid or 10−5 M gamma-linolenic to charcoal-stripped medium decreased the affinity of the antiestrogen-binding protein. In contrast, growth in 10−5 M stearic acid or 10−5 M oleic acid did not significantly alter the affinity of the antiestrogen-binding protein, whereas 10−5 M palmitic acid significantly increased its affinity. The same fatty acids were also tested for their intrinsic effects on EL4 cell proliferation. Oleic, linoleic and gamma-linolenic acids were growth stimulatory while stearic and palmitic acids were not. Thus linoleic and gamma-linolenic acids whose presence in the growth medium was associated with decreased affinity of [3H]tamoxifen (1-[4-(2-dimethylaminoethoxy)phenyl]-1,2-diphenylbut-1(Z)-ene) binding to the intracellular antiestrogen-binding protein were also growth stimulatory. Unsaturated fatty acids have previously been shown to inhibit binding of [3H]tamoxifen to the antiestrogen-binding protein in a cell-free system. The present observations demonstrate that unsaturated fatty acids also modify the affinity of the antiestrogen-binding protein in intact cells.

Key words

Antiestrogens antiestrogen-binding protein cell proliferation fatty acids lymphocytes estrogen receptor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. 1.
    Jordan, V.C., Pharmac. Rev.36 (1984) 245.Google Scholar
  2. 2.
    Sutherland, R.L., Watts, C.K.W., and Ruenitz, P.C., Biochem. biophys. Res. Commun.140 (1986) 523.PubMedGoogle Scholar
  3. 3.
    Sutherland, R.L., Watts, C.K.W., Hall, R.E., and Ruenitz, P.C., J. Steroid Biochem.27 (1987) 891.PubMedGoogle Scholar
  4. 4.
    O'Brian, C.A., Liskamp, R.M., Solomon, D.H., and Weinstein, I.B., J. natl Cancer Inst.76, (1986) 1243.PubMedGoogle Scholar
  5. 5.
    Sartor, P., Vacher, P., Mollard, P., and Dufy, B., Endocrinology123 (1988) 534.PubMedGoogle Scholar
  6. 6.
    Lam, P.H.-Y., Biochem. biophys. Res. Commun.118 (1984) 27.PubMedGoogle Scholar
  7. 7.
    Faye, J.-C., Jozan, S., Redeuilh, G., Baulieu, E.-E., and Bayard, F., Proc. natl Acad. Sci. USA80 (1983) 3158.PubMedGoogle Scholar
  8. 8.
    Sutherland, R.L., Murphy, L.C., Foo, M.S., Green, M.D., Whybourne, A.M., and Krozowski, Z.S., Nature288 (1980) 273.PubMedGoogle Scholar
  9. 9.
    Watts, C.K.W., Murphy, L.C., and Sutherland R.L., J. biol. Chem.259 (1984) 4223.PubMedGoogle Scholar
  10. 10.
    Matin, A., Hwang, P.L.H., and Kon, O.L., Biochim. biophys. Acta931 (1987) 364.PubMedGoogle Scholar
  11. 11.
    Kon, O.L., Biochim. biophys. Acta843 (1985) 245.PubMedGoogle Scholar
  12. 12.
    Kon, O.L., J. biol. Chem.258 (1983) 3173.PubMedGoogle Scholar
  13. 13.
    Westley, B., and Rochefort, H., Cell20 (1980) 353.PubMedGoogle Scholar
  14. 14.
    Mishell, B.B., Shiigi, S.M., Henry, C., Chan, E.L., North, J., Gallily, R., Slomich, M., Miller, K., Marbrook, J., Parks, D., and Good, A.H., in: Selected Methods in Cellular Immunology, pp. 3–27. Eds B.B. Mishell and S.M. Shigii. W.H. Freeman, San Francisco 1980.Google Scholar
  15. 15.
    Lindsey, J.A., Zhang, H., Kaseki, H., Morisaki, N., Sato, T., and Cornwell, D.G., Lipids20 (1985) 151.PubMedGoogle Scholar
  16. 16.
    Kon, O.L., Webster, R.A., and Spelsberg, T.C., Endocrinology107 (1980) 1182.PubMedGoogle Scholar
  17. 17.
    Kon, O.L., and Spelsberg, T.C., Endorcinology111 (1982) 1925.Google Scholar
  18. 18.
    Soulinna, E.-M., Buchsbaum, R.N., and Racker, E., Cancer Res.35 (1975) 1865.PubMedGoogle Scholar
  19. 19.
    Hwang, P.L.H., Biochem. J.237 (1986) 749.PubMedGoogle Scholar
  20. 20.
    Hwang, P.L.H., Biochem. J.243 (1987) 359.PubMedGoogle Scholar
  21. 21.
    Murphy, P.R., Breckenridge, W.C., and Lazier, C.B., Biochem. biophys. Res. Commun.127 (1985) 786.PubMedGoogle Scholar
  22. 22.
    Hwang, P.L.H., and Matin, A., J., Lipid Res.30 (1989) 239.Google Scholar
  23. 23.
    Gulino, A., Screpanti, I., and Pasqualini, J.R., Endocrinology113 (1983) 1754.PubMedGoogle Scholar
  24. 24.
    Blatt, J., Rotenstein, D., and Dienes, S., Br. J. Cancer50 (1984) 837.PubMedGoogle Scholar
  25. 25.
    Mandeville, R., Ghali, S.S., and Chausseau, J.-P., Eur. J. Cancer clin. Oncol.20 (1984) 983.PubMedGoogle Scholar
  26. 26.
    Baral, E., Blomgren, H., Wasserman, J., Rotstein, S., and von Stedingk, L.-V., J. clin. Lab. Immun.21 (1986) 137.Google Scholar
  27. 27.
    Screpanti, I., Santoni, A., Gulino, A., Herberman, R.B., and Frati, L., Cell. Immun.106 (1987) 191.Google Scholar
  28. 28.
    Scambia, G., Panici, P.B., Maccio, A., Castelli, P., Serri, F., Mantovani, G., Massidda, B., Iacobelli, S., Del Giacco, S., and Mancuso, S., Cancer61 (1988) 2214.PubMedGoogle Scholar
  29. 29.
    Rotstein, S., Blomgren, H., Petrini, B., Wasserman, J., and von Stedingk, L.-V., Breast Cancer Res. Treat.12 (1988) 75.PubMedGoogle Scholar
  30. 30.
    Sheard, C.R., Reilly, F., Tee, D.E.H., Vergani, D., Lowe, D., Baum, M., and Cameron, A.E.P., Br. J. Cancer54 (1986) 705.PubMedGoogle Scholar
  31. 31.
    Baral, E., Kwok, S., and Berczi, I., Immunopharmacology18 (1989) 57.PubMedGoogle Scholar
  32. 32.
    Narasimhan, P., New Engl. J. Med.311 (1984) 1258.PubMedGoogle Scholar
  33. 33.
    Millis, R.R., Bobrow, L.G., Rubens, R.D., and Isaacson, P.G., Br. J. Cancer58 (1988) 808.PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel 1990

Authors and Affiliations

  • Y. K. Hoh
    • 1
  • E. H. Lim
    • 1
  • S. O. Ooi
    • 1
  • O. L. Kon
    • 1
  1. 1.Department of BiochemistryNational University of SingaporeSingaporeRepublic of Singapore

Personalised recommendations